跳至主要内容
临床试验/NCT02902276
NCT02902276Unknown不适用

Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
120
试验地点
1
主要终点
Plasma citrulline concentration

研究概览

简要总结

In critically ill patients, the small bowel permeability is increased, leading to bacterial translocation, and systemic inflammatory response syndrome.

Plasma citrulline is a validated biomarker of functional enterocyte mass. Lipopolysaccharide (LPS) is a part of Gram negative bacteria, and plasma LPS concentration is a biomarker of bacterial translocation. The link between plasma citrulline and LPS in the critically ill is unknown. Investigators hypothesize that patients presenting with low plasma citrulline concentration, with presumed altered small bowel function, would have an increased phenomenon of bacterial translocation, and increased plasma LPS concentration. Investigators aimed to evaluate the link between plasma citrulline and LPS concentrations in critically ill patients at the time of ICU admission.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Critically ill patients requiring ICU admission for at least 48 hours

排除标准

  • Chronic small bowel disease
  • Chronic renal failure (clearance of creatinine < 50 mL/min)
  • Pregnancy

结局指标

主要结局

Plasma citrulline concentration

时间窗: Up to 12 hours after admission in the unit

biological assay

plasma lipopolysaccharide concentration

时间窗: Up to 12 hours after admission in the unit

biological assay

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验